drug discovery

Main navigation

Year in review 2022

14 Dec 2022

The Neuro’s health care workers, staff, students and faculty have made great strides in patient care and neurological disease research. Here are some of our top stories from 2022.

Read more about Year in review 2022

Q & A with the Early Drug Discovery Unit’s new director

17 Jan 2022

We spoke to Tom Durcan about his new position, the role of stem cells in disease research and some exciting new developments at the EDDU.

Read more about Q & A with the Early Drug Discovery Unit’s new director

The Neuro partners with new consortium EUbOPEN to unlock disease biology

8 Jun 2020

The Neuro is one of only three non-EU associated partners in newly formed consortium EUbOPEN, focused on generating open-access tools to unlock disease biology, with a budget of 66 million euros.

Read more about The Neuro partners with new consortium EUbOPEN to unlock disease biology

Passion for science leads Rhalena Thomas to The Neuro to find a cure for Parkinson's disease

20 Dec 2019

Dr. Rhalena Thomas is an HBHL Postdoctoral Fellow who uses computational biology to study genes implicated in Parkinson’s disease.

Read more about Passion for science leads Rhalena Thomas to The Neuro to find a cure for Parkinson's disease

Why I'm giving my data away

9 Jul 2019

There hasn't been a breakthrough in Parkinson's research since the 1960s. That’s why Thomas Durcan is making his lab's methods available to anyone who wants them.

Read more about Why I'm giving my data away

The Neuro logo

The Neuro (Montreal Neurological Institute-Hospital) is a bilingual academic healthcare institution. We are a McGill research and teaching institute; delivering high-quality patient care, as part of the Neuroscience Mission of the McGill University Health Centre. We are proud to be a Killam Institution, supported by the Killam Trusts.